1999
DOI: 10.1002/1531-8249(199901)45:1<111::aid-art17>3.0.co;2-n
|View full text |Cite
|
Sign up to set email alerts
|

D-2-Hydroxyglutaric aciduria: Biochemical marker or clinical disease entity?

Abstract: D‐2‐Hydroxyglutaric aciduria has been observed in patients with extremely variable clinical symptoms, creating doubt about the existence of a disease entity related to the biochemical finding. An international survey of patients with D‐2‐hydroxyglutaric aciduria was initiated to solve this issue. The clinical history, neuroimaging, and biochemical findings of 17 patients were studied. Ten of the patients had a severe early‐infantile‐onset encephalopathy characterized by epilepsy, hypotonia, cerebral visual fai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
64
0
1

Year Published

2003
2003
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(66 citation statements)
references
References 52 publications
1
64
0
1
Order By: Relevance
“…Cardiomyopathy requiring treatment is frequently observed in type II D2HGA patients (Kranendijk et al 2010b(Kranendijk et al , 2012. Although 2HG levels fluctuate in the same individuals (van der Knaap et al 1999), patients who have IDH2 mutations generally have twofold to eightfold higher 2HG levels than those who have mutations in D2HGDH (Kranendijk et al 2010a).…”
mentioning
confidence: 99%
“…Cardiomyopathy requiring treatment is frequently observed in type II D2HGA patients (Kranendijk et al 2010b(Kranendijk et al , 2012. Although 2HG levels fluctuate in the same individuals (van der Knaap et al 1999), patients who have IDH2 mutations generally have twofold to eightfold higher 2HG levels than those who have mutations in D2HGDH (Kranendijk et al 2010a).…”
mentioning
confidence: 99%
“…Additional biochemical abnormalities include increased l-lysine in the CSF of L-2-HGA patients (9,10 ), regularly increased urinary Krebs cycle intermediates (especially succinate, 2-ketoglutarate, and citrate) in D-2-HGA (3,4 ), and increased excretion of 2-ketoglutarate in D/L-2-HGA (7 ).…”
mentioning
confidence: 99%
“…Increased urinary excretion of L-2 hydroxyglutaric acid, typical MRI findings, and L2HGDH gen mutation established the L2HGA diagnosis. To our knowledge, there are no previous reports of a patient with DCM and L2HGA; however, patients with DCM and D-2 hydroxyglutaric aciduria (D2HGA) have been discussed (4,5).…”
Section: Discussionmentioning
confidence: 99%